High STAT4 Expression is a Better Prognostic Indicator in Patients with Hepatocellular Carcinoma After Hepatectomy-Reference-Cited by-同舟云学术

High STAT4 Expression is a Better Prognostic Indicator in Patients with Hepatocellular Carcinoma After Hepatectomy

Published:2014-06-26 Issue:S4 Volume:21 Page:721-728
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Wubetu Gizachew Yismaw,Utsunomiya Tohru,Ishikawa Daichi,Yamada Shinichiro,Ikemoto Tetsuya,Morine Yuji,Iwahashi Shuichi,Saito Yu,Arakawa Yusuke,Imura Satoru,Kanamoto Mami,Zhu Chengzhan,Bando Yoshimi,Shimada Mitsuo

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-014-3861-9.pdf

Reference38 articles.

1. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 2002;31:339–46.

2. Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

3. El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol. 2002;35:72–8.

4. Huang YH, Chen CH, Chang TT, et al. The role of transcatheter arterial embolization in patients with resectable hepatocellular carcinoma: a nation-wide, multicenter study. Liver Int. 2004;24:419–24.

5. Yu H and Jove R. The STATs of cancer: new molecular targets come of age. Nature Rev Cancer. 2004;4:97–105.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer;Molecular and Cellular Biochemistry;2024-03-22

2. Assessment of STAT4 Variants and Risk of Hepatocellular Carcinoma in Latin Americans and Europeans;Cancers;2023-09-12

3. STAT4, a potential predictor of prognosis, promotes CD8 T‑cell infiltration in ovarian serous carcinoma by inducing CCL5 secretion;Oncology Reports;2023-05-31

4. Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis;Oncotarget;2022-11-22

5. STAT4 genetic polymorphism significantly affected HBeAg seroconversion in HBeAg‐positive chronic hepatitis B patients receiving Peginterferon‐α therapy: A prospective cohort study in China;Journal of Medical Virology;2022-06